PEP-010 has received orphan drug designation for pancreatic cancer, emphasizing the need for novel treatments in this high-mortality disease. The peptide disrupts Caspase-9 and PP2A interaction, ...
Please provide your email address to receive an email when new articles are posted on . Quarterly chlamydia positivity dropped from 9.6% before doxy-PEP initiation to 2% afterwards among users.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results